A biotech startup based in Uruguay has successfully completed early-stage human trials for a first-in-class drug that targets fat cells to burn more calories, even while the body is at rest. Developed ...

Lonapegsomatropin is a pegylated prodrug of the human growth hormone, somatropin, administered as a subcutaneous injection once-weekly.

Apnimed, a pharmaceutical company developing oral therapies for obstructive sleep apnea (OSA) and related conditions, announced positive topline results from its second pivotal Phase 3 trial of AD109 ...